104 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
16
Green fluorescent protein chromophore derivatives as a new class of aldose reductase inhibitors.
Toho University
1
Characterization of Emodin as a Therapeutic Agent for Diabetic Cataract.
University of Colorado
6
Thiazolidine-2,4-dione derivatives: programmed chemical weapons for key protein targets of various pathological conditions.
Punjabi University
19
Identification of novel aldose reductase inhibitors based on carboxymethylated mercaptotriazinoindole scaffold.
Slovak Academy of Sciences
5
Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions.
University of Messina
9
20(S)-Ginsenoside Rh2 as aldose reductase inhibitor from Panax ginseng.
Kyushu University
19
Synthesis and structure-activity relationship of 2-phenyliminochromene derivatives as inhibitors for aldo-keto reductase (AKR) 1B10.
Gifu Pharmaceutical University
20
Synthesis of organic nitrates of luteolin as a novel class of potent aldose reductase inhibitors.
Xiangtan University
129
Synopsis of some recent tactical application of bioisosteres in drug design.
Bristol Myers Squibb
9
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
Gifu Pharmaceutical University
110
Development of potent and selective inhibitors of aldo-keto reductase 1C3 (type 5 17ß-hydroxysteroid dehydrogenase) based on N-phenyl-aminobenzoates and their structure-activity relationships.
University of Pennsylvania
17
Optimization of the Central Core of Indolinone-Acetic Acid-Based CRTH2 (DP2) Receptor Antagonists.
TBA
9
Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivatives.
University of Messina
9
Inhibition of 3(17)alpha-hydroxysteroid dehydrogenase (AKR1C21) by aldose reductase inhibitors.
Monash University
2
Structural basis for the high all-trans-retinaldehyde reductase activity of the tumor marker AKR1B10.
Universitat Aut£Noma De Barcelona
5
Substituted pyrrol-1-ylacetic acids that combine aldose reductase enzyme inhibitory activity and ability to prevent the nonenzymatic irreversible modification of proteins from monosaccharides.
Aristotle University of Thessaloniki
11
Molecular modeling of the aldose reductase-inhibitor complex based on the X-ray crystal structure and studies with single-site-directed mutants.
National Eye Institute
26
Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.
Wyeth-Ayerst Research
57
Hydantoin bioisosteres. In vivo active spiro hydroxy acetic acid aldose reductase inhibitors.
Pfizer
25
A highly specific aldose reductase inhibitor, ethyl 1-benzyl-3-hydroxy-2(5H)-oxopyrrole-4-carboxylate, and its congeners.
Pfizer
21
Design, synthesis, and biological evaluation of novel (1-thioxo-1,2,3,4-tetrahydro-ß-carbolin-9-yl)acetic acids as selective inhibitors for AKR1B1.
University of Toyama
19
Construction of an Indonesian herbal constituents database and its use in Random Forest modelling in a search for inhibitors of aldose reductase.
King'S College London
24
Design, synthesis and evaluation of caffeic acid phenethyl ester-based inhibitors targeting a selectivity pocket in the active site of human aldo-keto reductase 1B10.
Gifu Pharmaceutical University
17
Structure-activity relationships of ganoderma acids from Ganoderma lucidum as aldose reductase inhibitors.
Sepuluh Nopember Institute of Technology
1
(2-Benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-8-yl)-acetic acid: an aldose reductase inhibitor and antioxidant of zwitterionic nature.
Slovak Academy of Sciences
48
Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists-discovery of AZD1981.
AstraZeneca
122
Discovery of potent, selective, and orally bioavailable alkynylphenoxyacetic acid CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
Merck Serono
4
Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.
The Institute For Diabetes Discovery
8
Furoxan nitric oxide donor coupled chrysin derivatives: synthesis and vasculoprotection.
Central South University
23
In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors.
University of Messina
16
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
University of Toyama
9
Chromene-3-carboxamide derivatives discovered from virtual screening as potent inhibitors of the tumour maker, AKR1B10.
Gifu Pharmaceutical University
4
Evaluation of aldose reductase inhibition and docking studies of 6'-nitro and 6',6''-dinitrorosmarinic acids.
National Hellenic Research Foundation
7
Design and synthesis of novel series of pyrrole based chemotypes and their evaluation as selective aldose reductase inhibitors. A case of bioisosterism between a carboxylic acid moiety and that of a tetrazole.
Aristotle University of Thessaloniki
1
Inhibition of aldose reductase from cataracted eye lenses by finger millet (Eleusine coracana) polyphenols.
Central Food Technological Research Institute
1
Development of Novel Phthalazinone-Triazole Hybrids as Potential Antidiabetic Agents Targeting GLUT4 Translocation in Skeletal Muscle.
CSIR-Central Drug Research Institute BS
70
In Search for Inhibitors of Human Aldo-Keto Reductase 1B10 (AKR1B10) as Novel Agents to Fight Cancer and Chemoresistance: Current State-of-the-Art and Prospects.
University of Messina
3
Inhibition of LPS-induced inflammatory response in RAW264.7 cells by natural Chlorogenic acid isomers involved with AKR1B1 inhibition.
University of Science and Technology of China
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.
Johann Wolfgang Goethe University
4
Synthetic GPR40/FFAR1 agonists: An exhaustive survey on the most recent chemical classes and their structure-activity relationships.
Jadavpur University
28
Validation of an automated procedure for the prediction of relative free energies of binding on a set of aldose reductase inhibitors.
Università
14
Designed multiple ligands for the treatment of type 2 diabetes mellitus and its complications: Discovery of (5-arylidene-4-oxo-2-thioxothiazolidin-3-yl)alkanoic acids active as novel dual-targeted PTP1B/AKR1B1 inhibitors.
University of Messina
11
Novel rhodanine based inhibitors of aldose reductase of non-acidic nature with p-hydroxybenzylidene functional group.
Charles University
70
Development of Biaryl-Containing Aldo-Keto Reductase 1C3 (AKR1C3) Inhibitors for Reversing AKR1C3-Mediated Drug Resistance in Cancer Treatment.
China Pharmaceutical University
23
Identification of a Selective SCoR2 Inhibitor That Protects Against Acute Kidney Injury.
Case Western Reserve University School of Medicine
5
Oxazolidinones as versatile scaffolds in medicinal chemistry.
University College London
19
Oxindole: A chemical prism carrying plethora of therapeutic benefits.
Punjabi University
101
Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus.
Aristotle University of Thessaloniki
18
Recent research progress on natural small molecule bibenzyls and its derivatives in Dendrobium species.
Chengdu University
1
Overview of piperlongumine analogues and their therapeutic potential.
Nantong University
22
Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect.
Northwest University
3
Structure of aldehyde reductase holoenzyme in complex with the potent aldose reductase inhibitor fidarestat: implications for inhibitor binding and selectivity.
Monash University (Parkville Campus)
4
High-resolution structures of human aldose reductase holoenzyme in complex with stereoisomers of the potent inhibitor Fidarestat: stereospecific interaction between the enzyme and a cyclic imide type inhibitor.
Monash University (Parkville Campus)
10
Synthesis, activity, and molecular modeling studies of novel human aldose reductase inhibitors based on a marine natural product.
Instituto Biomar
4
Synthesis and biological screening of thiosemicarbazones of substituted 3-acetylcoumarins having d-glucose moiety.
Institute For Advanced Technology (Vietnam Academy of Military Science and Technology)
19
Overview of AKR1C3: Inhibitor Achievements and Disease Insights.
China Pharmaceutical University
10
Early identification of promiscuous attributes of aldose reductase inhibitors using a DMSO-perturbation assay.
Kyushu University
3
A potent aldose reductase inhibitor, (2S,4S)-6-fluoro-2', 5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide (Fidarestat): its absolute configuration and interactions with the aldose reductase by X-ray crystallography.
Rational Drug Design Laboratories
10
Synthesis and molecular modeling of novel non-sulfonylureas as hypoglycemic agents and selective ALR2 inhibitors.
Suez Canal University
16
Synthesis of new arylsulfonylspiroimidazolidine-2',4'-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stress.
Quaid-I-Azam University
5
Development of Novel Oxotriazinoindole Inhibitors of Aldose Reductase: Isosteric Sulfur/Oxygen Replacement in the Thioxotriazinoindole Cemtirestat Markedly Improved Inhibition Selectivity.
Comenius University In Bratislava
30
Synthesis and biological activity of structurally diverse phthalazine derivatives: A systematic review.
Y. B. Chavan College of Pharmacy
19
An investigation on 4-thiazolidinone derivatives as dual inhibitors of aldose reductase and protein tyrosine phosphatase 1B, in the search for potential agents for the treatment of type 2 diabetes mellitus and its complications.
University of Messina
6
Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment.
University of Hradec Kralove
2
Design of an amide N-glycoside derivative of β-glucogallin: a stable, potent, and specific inhibitor of aldose reductase.
University of Colorado Anschutz Medical Campus
1
Synthesis and aldose reductase inhibitory activity of 7-sulfamoylxanthone-2-carboxylic acids.
TBA
4
New phenolic and quinone-methide triterpenes from Maytenus amazonica.
Universidad De La Laguna
7
Structures and aldose reductase inhibitory effects of bromophenols from the red alga Symphyocladia latiuscula.
Jilin Province Academy of Traditional Chinese Medicine and Materia Medica
1
Synthesis, absolute configuration, and conformation of the aldose reductase inhibitor sorbinil.
TBA
11
Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications.
TBA
19
Antiinflammatory and aldose reductase inhibitory activity of some tricyclic arylacetic acids.
TBA
11
Structure optimization of tetrahydropyridoindole-based aldose reductase inhibitors improved their efficacy and selectivity.
Slovak Academy of Sciences
30
Rotationally restricted mimics of rigid molecules: nonspirocyclic hydantoin aldose reductase inhibitors.
Pfizer
18
Gossypol and derivatives: a new class of aldose reductase inhibitors.
University of New Mexico School of Medicine
2
1-Acetyl-5-phenyl-1H-pyrrol-3-ylacetate: An aldose reductase inhibitor for the treatment of diabetic nephropathy.
Shanghai Institute of Pharmaceutical Industry
84
Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congeners.
Pfizer
64
Potent, orally active aldose reductase inhibitors related to zopolrestat: surrogates for benzothiazole side chain.
Pfizer
29
Orally active aldose reductase inhibitors: indazoleacetic, oxopyridazineacetic, and oxopyridopyridazineacetic acid derivatives.
Pfizer
56
Biological activities and quantitative structure-activity relationships of spiro[imidazolidine-4,4'(1'H)-quinazoline]-2,2',5(3'H)-triones as aldose reductase inhibitors.
Tanabe Seiyaku
19
Synthesis of Potent and Selective Inhibitors of Aldo-Keto Reductase 1B10 and Their Efficacy against Proliferation, Metastasis, and Cisplatin Resistance of Lung Cancer Cells.
Gifu Pharmaceutical University
56
C6-spiro iminothiadiazine dioxides as BACE inhibitors, compositions, and their use
Merck Sharp & Dohme
4
Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals
Takeda Pharmaceutical
7
Small molecule antagonists of phosphatidylinositol-3,4,5-triphosphate (PIP3) and uses thereof
Tufts University
12
A Novel Approach to the Discovery of Small-Molecule Ligands of CDK2.
Moffitt Cancer Center